BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2251113)

  • 1. Initiation of transcription of the erythroid promoter of the porphobilinogen deaminase gene is regulated by a cis-acting sequence around the cap site.
    Beaupain D; Eléouët JF; Roméo PH
    Nucleic Acids Res; 1990 Nov; 18(22):6509-15. PubMed ID: 2251113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCACC-binding or simian-virus-40-protein-1-binding proteins cooperate with human GATA-1 to direct erythroid-specific transcription and to mediate 5' hypersensitive site 2 sensitivity of a TATA-less promoter.
    Eleouet JF; Roméo PH
    Eur J Biochem; 1993 Mar; 212(3):763-70. PubMed ID: 8385011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene.
    Mignotte V; Eleouet JF; Raich N; Romeo PH
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6548-52. PubMed ID: 2771941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression.
    Chretien S; Dubart A; Beaupain D; Raich N; Grandchamp B; Rosa J; Goossens M; Romeo PH
    Proc Natl Acad Sci U S A; 1988 Jan; 85(1):6-10. PubMed ID: 3422427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene.
    Mignotte V; Wall L; deBoer E; Grosveld F; Romeo PH
    Nucleic Acids Res; 1989 Jan; 17(1):37-54. PubMed ID: 2911469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between the NF-E1 erythroid-specific transcription factor and the CACCC factor in the erythroid-specific promoter of the human porphobilinogen deaminase gene.
    Frampton J; Walker M; Plumb M; Harrison PR
    Mol Cell Biol; 1990 Jul; 10(7):3838-42. PubMed ID: 2355926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the human beta-globin downstream promoter region.
    Leach KM; Vieira KF; Kang SH; Aslanian A; Teichmann M; Roeder RG; Bungert J
    Nucleic Acids Res; 2003 Feb; 31(4):1292-301. PubMed ID: 12582249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulated expression of the overlapping ubiquitous and erythroid transcription units of the human porphobilinogen deaminase (PBG-D) gene introduced into non-erythroid and erythroid cells.
    Raich N; Mignotte V; Dubart A; Beaupain D; Leboulch P; Romana M; Chabret C; Charnay P; Papayannopoulou T; Goossens M
    J Biol Chem; 1989 Jun; 264(17):10186-92. PubMed ID: 2542327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mouse porphobilinogen deaminase gene. Structural organization, sequence, and transcriptional analysis.
    Beaumont C; Porcher C; Picat C; Nordmann Y; Grandchamp B
    J Biol Chem; 1989 Sep; 264(25):14829-34. PubMed ID: 2768242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo protein--DNA interactions on the rat erythroid-specific L' pyruvate kinase gene promoter.
    Lacronique V; Boquet D; Lopez S; Kahn A; Raymondjean M
    Nucleic Acids Res; 1992 Nov; 20(21):5669-76. PubMed ID: 1454529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of DNase-I hypersensitive sites at the mouse porphobilinogen deaminase gene locus. Different requirements for position-independent expression from its two promoters.
    Porcher C; Picat C; Daegelen D; Beaumont C; Grandchamp B
    J Biol Chem; 1995 Jul; 270(29):17368-74. PubMed ID: 7615541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythroid AP-1/NF-E2 elements vary in their response to NF-E2.
    Walters M; Andrews NC; Magis W; Martin DI
    Exp Hematol; 1996 Feb; 24(3):445-52. PubMed ID: 8599974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two leaky-late HSV-1 promoters differ significantly in structural architecture.
    Lieu PT; Wagner EK
    Virology; 2000 Jun; 272(1):191-203. PubMed ID: 10873762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hypersensitive sites, protein-binding motifs, and regulatory elements in both promoters of the mouse porphobilinogen deaminase gene.
    Porcher C; Pitiot G; Plumb M; Lowe S; de Verneuil H; Grandchamp B
    J Biol Chem; 1991 Jun; 266(16):10562-9. PubMed ID: 2037597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-viral mediated gene transfer of porphobilinogen deaminase into mammalian cells.
    Johansson A; Möller C; Gellerfors P; Harper P
    Scand J Clin Lab Invest; 2002; 62(2):105-13. PubMed ID: 12004925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of human erythroid-specific porphobilinogen deaminase mRNA by the polymerase chain reaction.
    Lin JH; Grandchamp B; Abraham NG
    Exp Hematol; 1991 Sep; 19(8):817-22. PubMed ID: 1868896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATAAG; a cis-control region binding an erythroid-specific nuclear factor with a role in globin and non-globin gene expression.
    Plumb M; Frampton J; Wainwright H; Walker M; Macleod K; Goodwin G; Harrison P
    Nucleic Acids Res; 1989 Jan; 17(1):73-92. PubMed ID: 2911489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter elements of the mouse complement C4 gene critical for transcription activation and start site location.
    Miyagoe Y; Galibert MD; Georgatsou E; Fourel G; Meo T
    J Biol Chem; 1994 Mar; 269(11):8268-79. PubMed ID: 8132550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the imperfect octamer-containing human immunoglobulin VH6 gene promoter.
    Sun Z; Kitchingman GR
    Nucleic Acids Res; 1994 Mar; 22(5):850-60. PubMed ID: 8139927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and regulation of the nonerythroid porphobilinogen deaminase promoter.
    Lundin G; Anvret M
    Biochem Biophys Res Commun; 1997 Feb; 231(2):409-11. PubMed ID: 9070289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.